We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
Cap. Flow
-$21B
Cap. Flow %
-11.12%
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Healthcare 11.06%
3 Financials 8.17%
4 Consumer Discretionary 8.09%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MHN
4126
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
$207K ﹤0.01%
14,000
ACWV icon
4127
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.32B
$206K ﹤0.01%
+2,000
New +$204K
KRON
4128
DELISTED
Kronos Bio
KRON
$206K ﹤0.01%
+8,606
New +$218K
MBIN icon
4129
Merchants Bancorp
MBIN
$2.56B
$206K ﹤0.01%
7,841
-48
-0.6% -$1.33K
RRGB icon
4130
Red Robin
RRGB
$150M
$205K ﹤0.01%
+6,180
New +$211K
ZYXI
4131
DELISTED
Zynex
ZYXI
$205K ﹤0.01%
14,500
+612
+4% +$8.46K
FIRY
4132
CALL
Firy Inc
FIRY
$144M
$204K ﹤0.01%
+460
New +$164K
AWH
4133
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$204K ﹤0.01%
+2,418
New +$208K
RPTX
4134
DELISTED
Repare Therapeutics
RPTX
$201K ﹤0.01%
6,454
-2,062
-24% -$67.5K
ME
4135
DELISTED
23andMe Holding Co
ME
$201K ﹤0.01%
+858
New +$179K
EQNR icon
4136
Equinor
EQNR
$94.8B
$200K ﹤0.01%
9,454
-630,350
-99% -$13.3M
CTAC
4137
DELISTED
Cerberus Telecom Acquisition Corp.
CTAC
$200K ﹤0.01%
20,100
PNF
4138
DELISTED
PIMCO New York Municipal Income Fund
PNF
$199K ﹤0.01%
15,500
CZOO
4139
DELISTED
Cazoo Group Ltd
CZOO
$199K ﹤0.01%
10
-790
-99% -$15.8M
CVM icon
4140
CEL-SCI Corp
CVM
$21.8M
$198K ﹤0.01%
761
-261
-26% -$161K
SIGA icon
4141
SIGA Technologies
SIGA
$230M
$198K ﹤0.01%
31,672
-3,632
-10% -$25K
PRAX icon
4142
Praxis Precision Medicines
PRAX
$8.52B
$197K ﹤0.01%
+722
New +$259K
GTPA
4143
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
$197K ﹤0.01%
+19,603
New +$195K
OWL.WS
4144
DELISTED
Blue Owl Capital Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A C
OWL.WS
$195K ﹤0.01%
+70,986
New +$185K
TWI icon
4145
Titan International
TWI
$466M
$194K ﹤0.01%
23,715
-19,779
-45% -$193K
PV.U
4146
DELISTED
Primavera Capital Acquisition Corporation Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
PV.U
$194K ﹤0.01%
19,000
EPM icon
4147
Evolution Petroleum
EPM
$129M
$193K ﹤0.01%
+38,766
New +$152K
MMX
4148
DELISTED
Maverix Metals Inc. Common Shares
MMX
$193K ﹤0.01%
35,759
+2,403
+7% +$13.7K
K
4149
PUT
DELISTED
Kellanova
K
$192K ﹤0.01%
+3,195
New +$194K
FDD icon
4150
First Trust STOXX European Select Dividend Income Fund
FDD
$894M
$190K ﹤0.01%
+13,152
New +$196K

Similar funds

Credit Suisse's Q2 2021 Portfolio in Review

As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.

  • Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
  • Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
  • Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
  • Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
  • Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
  • Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
  • Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.